Ixabepilone
Toxicity in Hepatic Impairment
- This drug in combination with capecitabine is contraindicated in patients with AST or ALT > 2.5 x ULN or bilirubin >1 x ULN due to increased risk of toxicity and neutropenia related death See Contraindications and Warnings and Precautions.
Patient Counseling Information
Package Inserts
Additional Information
Updated January 2018